Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression

Oncogene

Volumn 35, Issue 37, 2016, Pages 4927-4936

  Huang, B ^a,b   Song, J H ^b   Cheng, Y ^b   Abraham, J M ^b   Ibrahim, S ^b   Sun, Z ^b   Ke, X ^b   Meltzer, S J ^b  

^a TONGJI UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; CYTOKERATIN 7; LONG UNTRANSLATED RNA; KRT7 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL CYCLE M PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA HYBRIDIZATION; RNA SEQUENCE; STEADY STATE; STOMACH CANCER; UPREGULATION; CELL MOTION; DISEASE EXACERBATION; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; STOMACH TUMOR;

CARCINOGENESIS; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-7; RNA, ANTISENSE; RNA, LONG NONCODING; STOMACH NEOPLASMS;

EID: 84958093154     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.25     Document Type: Article

References (45)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005; 128: 1567-1578.
3. Yamaguchi N, Kakizoe T. Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Lancet Oncol 2001; 2: 88-94.
4. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629-641.
5. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M et al. Antisense transcription in the mammalian transcriptome. Science 2005; 309: 1564-1566.
6. Wahlestedt C. Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov Today 2006; 11: 503-508.
7. Wight M, Werner A. The functions of natural antisense transcripts. Essays Biochem 2013; 54: 91-101.
8. Faghihi MA, Wahlestedt C. Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol 2009; 10: 637-643.
9. Villegas VE, Zaphiropoulos PG. Neighboring gene regulation by antisense long non-coding RNAs. Int J Mol Sci 2015; 16: 3251-3266.
10. Nishizawa M, Ikeya Y, Okumura T, Kimura T. Post-transcriptional inducible gene regulation by natural antisense RNA. Front Biosci (Landmark Ed) 2015; 20: 1-36.
11. Kimura T, Jiang S, Nishizawa M, Yoshigai E, Hashimoto I, Nishikawa M et al. Stabilization of human interferon-alpha1 mRNA by its antisense RNA. Cell Mol Life Sci 2013; 70: 1451-1467.
12. Thrash-Bingham CA, Tartof KD. aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J Natl Cancer Inst 1999; 91: 143-151.
13. Cayre A, Rossignol F, Clottes E, Penault-Llorca F. aHIF but not HIF-1alpha transcript is a poor prognostic marker in human breast cancer. Breast Cancer Res 2003; 5: R223-R230.
14. Span PN, Rao JU, Oude Ophuis SB, Lenders JW, Sweep FC, Wesseling P et al. Overexpression of the natural antisense hypoxia-inducible factor-1alpha transcript is associated with malignant pheochromocytoma/paraganglioma. Endocr Relat Cancer 2011; 18: 323-331.
15. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010; 38: 662-674.
16. Iacobucci I, Sazzini M, Garagnani P, Ferrari A, Boattini A, Lonetti A et al. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leuk Res 2011; 35: 1052-1059.
17. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet 2010; 6: e1000899.
18. Xi Q, Gao N, Zhang X, Zhang B, Ye W, Wu J et al. A natural antisense transcript regulates acetylcholinesterase gene expression via epigenetic modification in Hepatocellular Carcinoma. Int J Biochem Cell Biol 2014; 55: 242-251.
19. Su WY, Li JT, Cui Y, Hong J, Du W, Wang YC et al. Bidirectional regulation between WDR83 and its natural antisense transcript DHPS in gastric cancer. Cell Res 2012; 22: 1374-1389.
20. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008; 14: 723-730.
21. Michael DR, Phillips AO, Krupa A, Martin J, Redman JE, Altaher A et al. The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell. J Biol Chem 2011; 286: 19523-19532.
22. Carrieri C, Cimatti L, Biagioli M, Beugnet A, Zucchelli S, Fedele S et al. Long noncoding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 2012; 491: 454-457.
23. Salameh A, Lee AK, Cardo-Vila M, Nunes DN, Efstathiou E, Staquicini FI et al. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci USA 2015; 112: 8403-8408.
24. Karantza V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 2011; 30: 127-138.
25. Lambaudie E, Chereau E, Pouget N, Thomassin J, Minsat M, Charafe-Jauffret E et al. Cytokeratin 7 as a predictive factor for response to concommitant radiochemotherapy for locally advanced cervical cancer: a preliminary study. Anticancer Res 2014; 34: 177-181.
26. Oue N, Noguchi T, Anami K, Kitano S, Sakamoto N, Sentani K et al. Cytokeratin 7 is a predictive marker for survival in patients with esophageal squamous cell carcinoma. Ann Surg Oncol 2012; 19: 1902-1910.
27. Harbaum L, Pollheimer MJ, Kornprat P, Lindtner RA, Schlemmer A, Rehak P et al. Keratin 7 expression in colorectal cancer-freak of nature or significant finding? Histopathology 2011; 59: 225-234.
28. Pujal J, Huch M, Jose A, Abasolo I, Rodolosse A, Duch A et al. Keratin 7 promoter selectively targets transgene expression to normal and neoplastic pancreatic ductal cells in vitro and in vivo. FASEB J 2009; 23: 1366-1375.
29. Kanduc D. Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit alpha(1)-globin and human cytokeratin 7. J Virol 2002; 76: 7040-7048.
30. Sandilands A, Smith FJ, Lunny DP, Campbell LE, Davidson KM, MacCallum SF et al. Generation and characterisation of keratin 7 (K7) knockout mice. PLoS One 2013; 8: e64404.
31. Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS. Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Res 2007; 67: 10753-10758.
32. Yang X, Song JH, Cheng Y, Wu W, Bhagat T, Yu Y et al. Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 2014; 63: 881-890.
33. Medrzycki M, Zhang Y, Zhang W, Cao K, Pan C, Lailler N et al. Histone h1. 3 suppresses h19 noncoding RNA expression and cell growth of ovarian cancer cells. Cancer Res 2014; 74: 6463-6473.
34. Liang WC, Fu WM, Wong CW, Wang Y, Wang WM, Hu GX et al. The LncRNA H19 promotes epithelial to mesenchymal transition by functioning as MiRNA sponges in colorectal cancer. Oncotarget 2015; 6: 22513-22525.
35. Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J 2012; 279: 3159-3165.
36. Zhou X, Yin C, Dang Y, Ye F, Zhang G. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Sci Rep 2015; 5: 11516.
37. Saxonov S, Berg P, Brutlag DL. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci USA 2006; 103: 1412-1417.
38. Alam T, Medvedeva YA, Jia H, Brown JB, Lipovich L, Bajic VB. Promoter analysis reveals globally differential regulation of human long non-coding RNA and protein-coding genes. PLoS One 2014; 9: e109443.
39. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, expression. Genome Res 2012; 22: 1775-1789.
40. Balbin OA, Malik R, Dhanasekaran SM, Prensner JR, Cao X, Wu YM et al. The landscape of antisense gene expression in human cancers. Genome Res 2015; 25: 1068-1079.
41. Munroe SH, Zhu J. Overlapping transcripts, double-stranded RNA and antisense regulation: a genomic perspective. Cell Mol Life Sci 2006; 63: 2102-2118.
42. Schmid M, Olszewski P, Pelechano V, Gupta I, Steinmetz LM, Jensen TH. The Nuclear PolyA-Binding Protein Nab2p Is Essential for mRNA Production. Cell Rep 2015; 12: 128-139.
43. Faghihi MA, Zhang M, Huang J, Modarresi F, Van der Brug MP, Nalls MA et al. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 2010; 11: R56.
44. Tan JY, Sirey T, Honti F, Graham B, Piovesan A, Merkenschlager M et al. Extensive microRNA-mediated crosstalk between lncRNAs and mRNAs in mouse embryonic stem cells. Genome Res 2015; 25: 655-666.
45. Wu W, Bhagat TD, Yang X, Song JH, Cheng Y, Agarwal R et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2013; 144: 956-966 e954.